Capstone Financial Advisors, Inc. Moderna, Inc. Transaction History

Capstone Financial Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $618,657 - $1.35 Million	-2,788 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $4,936 - $8,929	-38 Reduced 1.34%	2,788 $655,000
Q1 2021 May 13, 2021	SELL	$109.18 - $185.98 $4,367 - $7,439	-40 Reduced 1.4%	2,826 $370,000
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $188,410 - $486,818	2,866 New	2,866 $299,000

953

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Capstone Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Capstone Financial Advisors, Inc. with notifications on news.